Fruitist secures $150 million investment for global berry expansion amid GLP-1 drug trend

Fruitist secures $150 million investment for global berry expansion amid GLP-1 drug trend

Leading jumbo blueberry distributor Fruitist raised $150 million in equity financing, backed primarily by JP Morgan Asset Management. The berry-specialized company has experienced significant growth over the past year and is now preparing for an accelerated global expansion, supported by investor confidence. 

The vertically integrated company has been making waves with its rebranded approach to blueberries. The firm’s strategy is founded in secured year-round supply through a diversified sourcing program that taps growers in Peru, Chile, Mexico, India, Morocco, China, and the United States. 

Fruitist blueberries

The company has bet big on a refreshing look and marketing strategy, but above all, on convenience. Its portfolio includes an array of snack-sized formats featuring premium and jumbo blueberries, as well as blackberries, raspberries, and cherries. 

The strategy has paid off, as consumers have responded positively, especially in the context of the rise of GLP-1 weight loss drugs. The semaglutide trend, led by names such as Ozempic, Mountjaro, and Wegovy, has revolutionized eating behavior, placing greater emphasis on healthy, nutrient-packed snacks and practicality. 

“Our data show that consumers using GLP-1 treatments increase their berry purchases after starting the medication,” said Fruistist founder and CEO, Steve Magami, to AgFunderNews

The executive explained to the news outlet that the firm is not only shifting market share between suppliers at retail, but is actually generating new purchases.

Invoking investor confidence for Fruitist

The market shift, plus Fruitist’s ability to stand out in a category where premium is drawing a clear divide in profits, has not gone unnoticed. 

Fruitist blueberries

In a statement to AgFunderNews, Brad Demong, managing director at JP Morgan Asset Management, said they recognized the firm's “exceptional results,” making it a sound move for its investment strategy. 

“We believe that Fruitist, with control of its value chain, significant organic growth opportunity ahead, and positioning as a driving force of premiumization of berries and the better-for-you category, will realize durable expansion,” Demong said.

*All images courtesy of Fruitist


Related stories

Agrovision rebrands, say hello to Fruitist

Global blueberry industry 2025 recap: The year of the "Blue Renaissance"

Subscribe to our newsletter


Subscribe